BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma

NCT07196124 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma Refractory

Interventions

BIOLOGICAL: BCMA/GPRC5D CAR-T

Sponsor

Guangzhou Bio-gene Technology Co., Ltd